Astrana Health executive logs small tax share surrender

Astrana Health, Inc. COO and CFO Basho Chandan reported a small tax-related share disposition.

Rhea-AI Filing Summary

Astrana Health, Inc. COO and CFO Basho Chandan reported a small tax-related share disposition. On April 2, 2026, he surrendered 2,092 shares of common stock at an assigned price of $25.05 per share to cover tax withholding obligations tied to restricted stock units that vested that day.

After this tax-withholding transaction, Chandan directly holds 171,635 shares of Astrana Health common stock. This figure includes unvested restricted stock and restricted stock units scheduled to vest over the next several years, subject to his continued employment with the company.

Insider Trade Summary

Exercise Price or Tax Liability: 2,092 shares

Exercise Price or Tax Liability 1 txn

Insider Basho Chandan

Role COO and CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,092	$25.05	$52K

Holdings After Transaction: Common Stock — 171,635 shares (Direct)

Footnotes (2)

1. F1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2026.
2. F2. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.

Key Figures

Shares surrendered for tax withholding: 2,092 shares Assigned share price: $25.05 per share Shares held after transaction: 171,635 shares +4 more

7 metrics

Shares surrendered for tax withholding 2,092 shares Common stock surrendered on April 2, 2026 for tax obligations on vested RSUs

Assigned share price $25.05 per share Value used for 2,092-share tax-withholding disposition

Shares held after transaction 171,635 shares Direct Astrana Health common stock holdings following April 2, 2026 transaction

Unvested restricted stock (near-term) 7,214 shares Restricted stock vesting on April 14, 2026, subject to continued employment

Additional unvested restricted stock 30,404 shares Vesting in two equal annual installments on May 16, 2026 and 2027

Unvested RSUs (grant 1) 15,604 RSUs Vesting in four equal semi-annual installments beginning October 2, 2026

Unvested RSUs (grant 2) 20,027 RSUs Vesting in six equal semi-annual installments beginning September 5, 2026

Key Terms

restricted stock units, tax withholding obligations, unvested restricted stock, semi-annual installments

4 terms

restricted stock units financial

"restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer)"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"surrender of shares to offset against tax withholding obligations associated with certain restricted stock units"

unvested restricted stock financial

"Includes the following shares of unvested restricted stock, which will vest as follows"

semi-annual installments financial

"restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Astrana Health (ASTH) report for Basho Chandan?

Astrana Health reported that COO and CFO Basho Chandan surrendered 2,092 shares of common stock on April 2, 2026. The shares were used to satisfy tax withholding obligations arising from restricted stock units that vested, rather than through an open-market sale.

Was the Astrana Health (ASTH) Form 4 transaction an open-market sale?

No. The Form 4 shows a tax-withholding disposition coded as “F,” meaning 2,092 shares were surrendered to cover taxes on vested restricted stock units. It does not represent a discretionary open-market sale of Astrana Health shares by the executive.

How many Astrana Health (ASTH) shares does Basho Chandan hold after this filing?

After the April 2, 2026 tax-withholding transaction, Basho Chandan directly holds 171,635 shares of Astrana Health common stock. This total includes both currently vested shares and unvested restricted stock that will vest over time, assuming continued employment.

What future vesting schedule is disclosed for Basho Chandan’s Astrana Health (ASTH) equity?

The filing notes 7,214 unvested restricted shares vesting on April 14, 2026 and 30,404 vesting in two annual installments on May 16, 2026 and 2027. It also discloses multiple restricted stock unit grants vesting in semi-annual installments starting in late 2026.

What does transaction code “F” mean in the Astrana Health (ASTH) Form 4?

Transaction code “F” indicates shares were surrendered to pay the exercise price or satisfy tax liabilities. Here, 2,092 Astrana Health shares were used to cover tax withholding on vested restricted stock units, rather than being sold on the open market for cash proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 05:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basho Chandan

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		F		2,092(1)	D	$25.05	171,635(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2026.

2. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.

	/s/ Kathy Diep, as Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)